The EU-India Free Trade Agreement, concluded recently after nearly two decades of negotiation, holds the promise of reshaping ...

At long last, the Trump administration’s much-ballyhooed tariffs on pharmaceutical imports are materializing in a trade deal with the European Union. Still, as with previous communications on the ...

The US-India interim trade deal provisionally continues to protect Indian pharmaceutical exports from Washington's reciprocal tariffs, pending a national security investigation.

John Flavin , Portal Innovations CEO, joins 'Fast Money' to discuss if there is still room to run in the biotech space. Got a confidential news tip? We want to hear from you. Sign up for free ...

India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.

The Korea Pharmaceutical Traders Association said Aug. 26 that it signed a strategic agreement with Korea Trade Insurance Corp. to support South Korean companies exporting biopharmaceutical materials ...